SPY769.86+0.03%QQQ749.55−0.00%BTC/USD84,599.88+0.12%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%
Benzinga

Aras Azadian

Aras Azadian is the chief executive officer of Modal, a biotechnology firm specializing in the development of novel therapeutic solutions. Under his leadership, the company advances research and innovation aimed at addressing unmet medical needs. Azadian is recognized for guiding strategic growth, fostering partnerships, and steering scientific projects toward commercialization.

Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today
Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY

Aras Azadian Recent News

Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced reported its interim second-quarter financial statements for the three months ending June 30, 2023.
This Cannabis Company Just Launched Medical Marijuana Care Platform And Finalized Important Acquisition
This Cannabis Company Just Launched Medical Marijuana Care Platform And Finalized Important Acquisition
Avicanna Inc.
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announced its initial portfolio offering and network in anticipation of the MyMedi.ca platform’s launch in e
Avicanna FY22 Revenue Grows 24%, Here Is What You Need To Know
Avicanna FY22 Revenue Grows 24%, Here Is What You Need To Know
Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) total fiscal 2022 revenue of CA$4 million representing growth of 24% from CA$3.3 million in fiscal 2021.
Avicanna Stock Jumps On Partnership With Shoppers Drug Mart
Avicanna Stock Jumps On Partnership With Shoppers Drug Mart
Shoppers Drug Mart has selected Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) as its partner to transition its Medical Cannabis by Shoppers business.
Avicanna Expands Its Pact With Al Harrington's Viola Brands To The UK
Avicanna Expands Its Pact With Al Harrington's Viola Brands To The UK
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a new sub-license agreement with VB Brands California LLC and Player Holdings LLC to exclusively commercialize its Viola-branded products in the United Kingdom territory where the company ha
Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference
Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference
Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:
Avicanna, Ei. Ventures Partner To Develop And Launch Functional Fungi-Based Products
Avicanna, Ei. Ventures Partner To Develop And Launch Functional Fungi-Based Products
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products has entered into an intellectual
EXCLUSIVE: How Avicanna Is Advancing Plant-Derived, Cannabinoid-Based Products
EXCLUSIVE: How Avicanna Is Advancing Plant-Derived, Cannabinoid-Based Products
Regulation is among the factors inhibiting the flow of capital to cannabis innovation. Institutions are afraid to invest, and “big pharma is not coming in as we would like to see happen.”
Avicanna's CBD Derma-Cosmetics To Reach European Union Market Via Bio-Gate Partnership
Avicanna's CBD Derma-Cosmetics To Reach European Union Market Via Bio-Gate Partnership
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) announced that it has executed a non-binding term sheet with Avicanna Inc.
Lab-Grown Cannabinoids: Is The Cannabis Market Ready?
Lab-Grown Cannabinoids: Is The Cannabis Market Ready?
Original publication date: November 9, 2020 4:30 pm
Avicanna Debuts CBD Derma-Cosmetics Pura H&W In US Via Deal With Red White & Bloom
Avicanna Debuts CBD Derma-Cosmetics Pura H&W In US Via Deal With Red White & Bloom
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Wednesday the
Avicanna & Al Harrington's CBD Wellness Launch New Sports Recovery-Based CBD Brand re+PLAY
Avicanna & Al Harrington's CBD Wellness Launch New Sports Recovery-Based CBD Brand re+PLAY
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) announced on Monday the launch of re+PLAY sports recovery-based CBD brand through a partnership with Harrington Wellness, founded by NBA veteran Al Harrington.
Cannabis Movers & Shakers: Aurora Cannabis, Dama Financial, Neptune Wellness, Avicanna
Cannabis Movers & Shakers: Aurora Cannabis, Dama Financial, Neptune Wellness, Avicanna
Dama Financial Appoints Industry Veteran Ed Labry As Executive Chairman Of Board Dama Financial, a provider of access to financial services for the cannabis industry, said Wednesday that it has named industry veteran Ed Labry as executive chairman of the board.
Cannabis Movers & Shakers: Synendos Therapeutics, Rapid Therapeutic Science Laboratories, Palo Santo, Avicanna
Cannabis Movers & Shakers: Synendos Therapeutics, Rapid Therapeutic Science Laboratories, Palo Santo, Avicanna
Synendos Therapeutics Appoints CNS Experts To Advisory Board Synendos Therapeutics, a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat central nervous system disorders, recently announced the appointment of CNS experts to form its scientific advisory board.
Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
Avicanna Inc., (TSX: AVCN) (OTCQX: AVCNF) a biopharmaceutical company focused on cannabinoid-based medicines, has filed a provisional patent application that aims to patent the use of a novel cannabinoid formulation for reducing or eliminating seizures and sudden death in epilepsy.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved